Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis

Applied and Environmental Microbiology

Volumn 72, Issue 9, 2006, Pages 6355-6363

  DelVecchio, Vito G ^a   Connolly, Joseph P ^a   Alefantis, Timothy G ^a   Walz, Alexander ^a   Quan, Marian A ^a   Patra, Guy ^a,d   Ashton, John M ^a   Whittington, Jessica T ^a   Chafin, Ryan D ^a   Liang, Xudong ^b   Grewal, Paul ^a   Khan, Akbar S ^c   Mujer, Cesar V ^a  

^a Vital Probes Inc   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c DEFENSE THREAT REDUCTION AGENCY   (United States)

^d SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CARBOHYDRATES; IONIZATION; LASER APPLICATIONS; MASS SPECTROMETRY; PROTEINS; VACCINES;

IMMUNODOMINANT; PROTEOMIC PROFILING; TIME OF FLIGHT MASS SPECTROMETRY;

BACTERIA;

ALANINE RACEMASE; AMINO ACID; ANTHRAX VACCINE; BACTERIAL ANTIGEN; CARBOHYDRATE; CHAPERONIN; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; DIHYDROLIPOAMIDE DEHYDROGENASE; ELONGATION FACTOR G; ELONGATION FACTOR TU; ENOLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NEUTRAL PROTEINASE; OXIDOREDUCTASE; PYRROLINE 5 CARBOXYLATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX; UNCLASSIFIED DRUG;

ANTIGEN; BACTERIUM; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOASSAY; MASS SPECTROMETRY; PROTEIN;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS THURINGIENSIS; BACTERIAL SPORE; BACTERIAL VIRULENCE; CARBOHYDRATE METABOLISM; CARBOHYDRATE TRANSPORT; ENERGY YIELD; GENOMICS; ISOELECTRIC POINT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; RNA TRANSLATION; SPECIES DIFFERENTIATION; UNINDEXED SEQUENCE;

ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS THURINGIENSIS; BACTERIAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENES, BACTERIAL; IMMUNODOMINANT EPITOPES; OPEN READING FRAMES; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPORES, BACTERIAL; VIRULENCE;

BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS CEREUS GROUP; BACILLUS THURINGIENSIS;

EID: 33748760583     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.00455-06     Document Type: Article

References (40)

1. a'Aldeen, D. A., A. H. Westphal, K. A. De, V. Weston, M. S. Atta, T. J. Baldwin, J. Bartley, and S. P. Borriello. 1996. Cloning, sequencing, characterization and implications for vaccine design of the novel dihydrolipoyl acetyltransferase of Neisseria meningitidis. J. Med. Microbiol. 45:419-432.
2. Ariel, N., A. Zvi, K. S. Makarova, T. Chitlaru, E. Elhanany, B. Velan, S. Cohen, A. M. Friedlander, and A. Shafferman. 2003. Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect. Immun. 71:4563-4579.
3. Bouillaut, L., N. Ramarao, C. Buisson, N. Gilois, M. Gohar, D. Lereclus, and C. Nielsen-Leroux. 2005. FIhA influences Bacillus thuringiensis PlcR-regulated gene transcription, protein production, and virulence. Appl. Environ. Microbiol. 71:8903-8910.
4. Brossier, F., M. Levy, and M. Mock. 2002. Anthrax spores make an essential contribution to vaccine efficacy. Infect. Immun. 70:661-664.
5. Cohen, S., I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany, T. Bino, M. Leitner, I. Inbar, H. Rosenberg, Y. Gozes, R. Barak, M. Fisher, C. Kronman, B. Velan, and A. Shafferman. 2000. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 68:4549-4558.
6. DesRosier, J. P., and J. C. Lara. 1984. Synthesis of the exosporium during sporulation of Bacillus cereus. J. Gen. Microbiol. 130:935-940.
7. Domingo, G. J., H. J. Chauhan, I. A. D. Lessard, C. Fuller, and R. N. Perham. 1999. Self-assembly and catalytic activity of the pyruvate dehydrogenase multienzyme complex from Bacillus stearothermophilus. Eur. J. Biochem. 266:1136-1146.
8. Drake, R. R., Y. Deng, E. E. Schwegler, and S. Gravenstein. 2005. Proteomics for biodefense applications: progress and opportunities. Expert Rev. Proteomics 2:203-213.
9. Dwyer, K. G., J. M. Lamonica, J. A. Schumacher, L. E. Williams, J. Bishara, A. Lewandowski, R. Redkar, G. Patra, and V. G. DelVecchio. 2004. Identification of Bacillus anthracis specific chromosomal sequences by suppressive subtractive hybridization. BMC Genomics 5:15-21.
10. Erttmann, K. D., A. Kleensang, E. Schneider, S. Hammerschmidt, D. W. Buttner, and M. Gallin. 2005. Cloning, characterization and DNA immunization of an Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (OV-GAPDH). Biochim. Biophys. Acta 1741:85-94.
11. Finco, O., A. Bonci, M. Agnusdei, M. Scarselli, R. Petracca, N. Norais, G. Ferrari, I. Garaguso, M. Donati, V. Sambri, R. Cevenini, G. Ratti, and G. Grandi. 2005. Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine 23:1178-1188.
12. Hachisuka, Y., K. Kojima, and T. Sato. 1966. Fine filaments on the outside of the exosporium of Bacillus anthracis spores. J. Bacteriol. 91:2382-2384.
13. Helgason, E., O. A. Økstad, D. A. Caugant, H. A. Johansen, A. Fouet, M. Mock, I. Hegna, and A. B. Kolsto. 2000. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Appl. Environ. Microbiol. 66:2627-2630.
14. Hernandez, E., F. Ramisse, J. P. Ducoureau, T. Cruel, and J. D. Cavallo. 1998. Bacillus thuringiensis subsp. Konkukian (serotype H34) superinfection: case report and experimental evidence of pathogenicity in immunosuppressed mice. J. Clin. Microbiol. 36:2138-2139.
15. Ibrahim, Y. M., A. R. Kerr, N. A. Silva, and T. J. Mitchell. 2005. Contribution of the ATP-dependent protease ClpCP to the autolysis and virulence of Streptococcus pneumoniae. Infect. Immun. 73:730-740.
16. Jomaa, M., J. M. Kyd, and A. W. Cripps. 2005. Mucosal immunisation with novel Streptococcus pneumoniae protein antigens enhances bacterial clearance in an acute mouse lung infection model. FEMS Immunol. Med. Microbiol. 44:59-67.
17. Kawai, K., Y. Liu, K. Ohnishi, and S. Oshima. 2004. A conserved 37 kDa outer membrane protein of Edwardsiella tarda is an effective vaccine candidate. Vaccine 22:3411-3418.
18. Khan, A. S., C. V. Mujer, T. G. Alefantis, J. P. Connolly, U. B. Mayr, P. Walcher, W. Lubitz, and V. G. DelVecchio. 2006. Proteomics and bioinformatics strategies for designing countermeasures against infectious threat agents. J. Chem. Infect. Model 46:111-115.
19. Klade, C. S. 2002. Proteomics approaches towards antigen discovery and vaccine development. Curr. Opin. Mol. Ther. 4:216-223.
20. Kudva, I. T., R. W. Griffin, J. M. Garren, S. B. Calderwood, and M. John. 2005. Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation. Infect. Immun. 73:5685-5696.
21. La Duc, M. T., M. Satomi, N. Agata, and K. Venkateswaran. 2004. gyrB as a phylogenetic discriminator for members of the Bacillus anthracis-cereus- thuringiensis group. J. Microbiol. Methods 56:383-394.
22. Leppla, S. H., J. B. Robbins, R. Schneerson, and J. Shiloach. 2002. Development of an improved vaccine for anthrax. J. Clin. Investig. 110:141-144.
23. Ling, E., G. Feldman, M. Portnoi, R. Dagan, K. Overweg, F. Mulholland, V. Chalifa-Caspi, J. Wells, and Y. Mizrachi-Nebenzahl. 2004. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin. Exp. Immunol. 138:290-298.
24. Liu, H., N. H. Bergman, B. Thomason, S. Shallom, A. Hazen, J. Crossno, D. A. Rasko, J. Ravel, T. D. Read, S. N. Peterson, J. Yates III, and P. C. Hanna. 2004. Formation and composition of the Bacillus anthracis endospore. J. Bacteriol. 186:164-178.
25. Liu, Y, S. Oshima, K. Kurohara, K. Ohnishi, and K. Kawai. 2005. Vaccine efficacy of recombinant GAPDH of Edwardsiella tarda against edwardsiellosis. Microbiol. Immunol. 49:605-612.
26. Lubitz, W. 2001. Bacterial ghosts as carrier and targeting systems. Expert Opin. Biol. Ther. 1:765-771.
27. March, J. B., C. D. Jepson, J. R. Clark, M. Totsika, and M. J. Calcutt. 2006. Phage library screening for the rapid identification and in vivo testing of candidate genes for a DNA vaccine against Mycoplasma mycoides subsp. mycoides small colony biotype. Infect. Immun. 74:167-174.
28. Matic, J. N., J. L. Wilton, R. J. Towers, A. L. Scarman, F. C. Minion, M. J. Walker, and S. P. Djordjevic. 2003. The pyruvate dehydrogenase complex of Mycoplasma hyopneumoniae contains a novel lipoyl domain arrangement. Gene 319:99-106.
29. Mignot, T., E. Couture-Tosi, S. Mesnage, M. Mock, and A. Fouet. 2004. In vivo Bacillus anthracis gene expression requires PagR as an intermediate effector of the AtxA signalling cascade. Int. J. Med. Microbiol. 293:619-624.
30. Mock, M., and A. Fouet. Anthrax. 2001. Annu. Rev. Microbiol. 55:647-671.
31. Schoeni, J. L., and A. C. Wong. 2005. Bacillus cereus food poisoning and its toxins. J. Food Prot. 68:636-648.
32. Shlyakhov, E. N., and E. Rubenstein. 1994. Human live anthrax vaccine in the former USSR. Vaccine 12:727-730.
33. Steichen, C., P. Chen, J. F. Kearney, and C. L. Turnbough, Jr. 2003. Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. J. Bacteriol. 185:1903-1910.
34. Sylvestre, P., E. Couture-Tosi, and M. Mock. 2002. A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol. Microbiol. 45:169-178.
35. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
36. Walcher, P., U. B. Mayr, C. Azimpour-Tabrizi, F. O. Eko, W. Jechlinger, P. Mayrhofer, T. Alefantis, C. V. Mujer, V. G. DelVecchio, and W. Lubitz. 2004. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors. Expert Rev. Vaccines 3:681-691.
37. Wang, J. Y., and M. H. Roehrl. 2005. Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin. Med. Immunol. 4:1-8.
38. Welkos, S. L., and A. M. Friedlander. 1988. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb. Pathog. 5:127-139.
39. Whiting, G. C., S. Rijpkema, T. Adams, and M. J. Corbel. 2004. Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis. Vaccine 22:4245-4251.
40. Zhu, P. P., and A. Peterkofsky. 1996. Sequence and organization of genes encoding enzymes involved in pyruvate metabolism in Mycoplasma capricolum. Protein Sci. 5:1719-1736.